166 related articles for article (PubMed ID: 27189608)
1. A web resource for mining HLA associations with adverse drug reactions: HLA-ADR.
Ghattaoraya GS; Dundar Y; González-Galarza FF; Maia MH; Santos EJ; da Silva AL; McCabe A; Middleton D; Alfirevic A; Dickson R; Jones AR
Database (Oxford); 2016; 2016():. PubMed ID: 27189608
[TBL] [Abstract][Full Text] [Related]
2. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations.
González-Galarza FF; Takeshita LY; Santos EJ; Kempson F; Maia MH; da Silva AL; Teles e Silva AL; Ghattaoraya GS; Alfirevic A; Jones AR; Middleton D
Nucleic Acids Res; 2015 Jan; 43(Database issue):D784-8. PubMed ID: 25414323
[TBL] [Abstract][Full Text] [Related]
3. An update on HLA alleles associated with adverse drug reactions.
Fricke-Galindo I; LLerena A; López-López M
Drug Metab Pers Ther; 2017 May; 32(2):73-87. PubMed ID: 28315856
[TBL] [Abstract][Full Text] [Related]
4. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools.
Gonzalez-Galarza FF; McCabe A; Santos EJMD; Jones J; Takeshita L; Ortega-Rivera ND; Cid-Pavon GMD; Ramsbottom K; Ghattaoraya G; Alfirevic A; Middleton D; Jones AR
Nucleic Acids Res; 2020 Jan; 48(D1):D783-D788. PubMed ID: 31722398
[TBL] [Abstract][Full Text] [Related]
5. Allele Frequency Net Database.
Gonzalez-Galarza FF; McCabe A; Melo Dos Santos EJ; Takeshita L; Ghattaoraya G; Jones AR; Middleton D
Methods Mol Biol; 2018; 1802():49-62. PubMed ID: 29858801
[TBL] [Abstract][Full Text] [Related]
6. A database for curating the associations between killer cell immunoglobulin-like receptors and diseases in worldwide populations.
Takeshita LY; Gonzalez-Galarza FF; dos Santos EJ; Maia MH; Rahman MM; Zain SM; Middleton D; Jones AR
Database (Oxford); 2013; 2013():bat021. PubMed ID: 23584834
[TBL] [Abstract][Full Text] [Related]
7. Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
Yip VL; Alfirevic A; Pirmohamed M
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):165-75. PubMed ID: 24777842
[TBL] [Abstract][Full Text] [Related]
8. Genetics and the potential for predictive tests in adverse drug reactions.
Pirmohamed M
Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
[TBL] [Abstract][Full Text] [Related]
9. Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs.
Hur J; Özgür A; He Y
J Biomed Semantics; 2018 Jun; 9(1):17. PubMed ID: 29880031
[TBL] [Abstract][Full Text] [Related]
10. HLA-SPREAD: a natural language processing based resource for curating HLA association from PubMed abstracts.
Dholakia D; Kalra A; Misir BR; Kanga U; Mukerji M
BMC Genomics; 2022 Jan; 23(1):10. PubMed ID: 34991484
[TBL] [Abstract][Full Text] [Related]
11. Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.
Karnes JH; Miller MA; White KD; Konvinse KC; Pavlos RK; Redwood AJ; Peter JG; Lehloenya R; Mallal SA; Phillips EJ
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():463-486. PubMed ID: 30134124
[TBL] [Abstract][Full Text] [Related]
12. A snapshot of human leukocyte antigen (HLA) diversity using data from the Allele Frequency Net Database.
Gonzalez-Galarza FF; McCabe A; Melo Dos Santos EJ; Jones AR; Middleton D
Hum Immunol; 2021 Jul; 82(7):496-504. PubMed ID: 33755549
[TBL] [Abstract][Full Text] [Related]
13. [Predictive genomic markers for severe adverse drug reactions].
Saito Y; Kodama S; Sugiyama E; Nakamura R
Yakugaku Zasshi; 2015; 135(4):589-95. PubMed ID: 25832839
[TBL] [Abstract][Full Text] [Related]
14. 16(th) IHIW: extending the number of resources and bioinformatics analysis for the investigation of HLA rare alleles.
Gonzalez-Galarza FF; Mack SJ; Hollenbach J; Fernandez-Vina M; Setterholm M; Kempenich J; Marsh SG; Jones AR; Middleton D;
Int J Immunogenet; 2013 Feb; 40(1):60-5. PubMed ID: 23198982
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of drug safety information using large-scale adverse drug reactions database].
Morikawa K
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):1-26. PubMed ID: 22259840
[TBL] [Abstract][Full Text] [Related]
16. Mining drug-target and drug-adverse drug reaction databases to identify target-adverse drug reaction relationships.
Galletti C; Bota PM; Oliva B; Fernandez-Fuentes N
Database (Oxford); 2021 Oct; 2021():. PubMed ID: 34679164
[TBL] [Abstract][Full Text] [Related]
17. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Cristallo AF; Schroeder J; Citterio A; Santori G; Ferrioli GM; Rossi U; Bertani G; Cassano S; Gottardi P; Ceschini N; Barocci F; Ribizzi G; Cutrupi V; Cairoli R; Rapisarda V; Pastorello EA; Barocci S
Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
[TBL] [Abstract][Full Text] [Related]
18. HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions.
Du T; Yang L; Luo H; Zhou P; Mei H; Xuan J; Xing Q; Ning B; Mendrick DL; Shi L
Biomark Med; 2015; 9(11):1079-93. PubMed ID: 26501190
[TBL] [Abstract][Full Text] [Related]
19. An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice.
Wang CW; Preclaro IAC; Lin WH; Chung WH
Front Pharmacol; 2022; 13():886377. PubMed ID: 35548363
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Kaniwa N; Saito Y
J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
